SCHEMBL7570879

SCHEMBL7570879

O[C@H](COc1ccc(-c2occ3cc(F)ccc23)cc1)CN1CCC(Oc2ccc(F)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.53
DRD4 P21917 5/20 0.53
DRD3 P35462 3/20 0.53
TSHR P16473 1/20 0.53
USP2 O75604 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CHRNA7 P36544 1/20 0.44
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HRH1 P35367 1/20 0.43
CCR3 P51677 1/20 0.43
CACNA1G O43497 3/20 0.43
KCNH2 Q12809 3/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382380 1.00 DRD2 (0.53) DRD2DRD4DRD3TSHRUSP2
SCHEMBL1382258 0.87 ATM (0.56) TSHRKMT2A
SCHEMBL7572169 0.86 PKM (0.57) TSHRUSP2KMT2A
SCHEMBL1383323 0.86 CHRNA7 (0.49) DRD2DRD4DRD3TSHRUSP2
SCHEMBL1381988 0.86 CHRNA7 (0.49) DRD2DRD4DRD3TSHRUSP2
SCHEMBL7572390 0.85 KDM4E (0.58) TSHRUSP2MEN1KMT2ACACNA1G
SCHEMBL7572751 0.84 HRH1 (0.49) DRD2DRD4DRD3TSHRUSP2
SCHEMBL7565949 0.81 KDM4E (0.51) DRD2DRD3USP2MEN1KMT2A
SCHEMBL7588884 0.80 ADRB3 (0.44) TSHRMEN1KMT2ACACNA1GKCNH2
SCHEMBL5368959 0.80 DRD2 (0.57) DRD2DRD4DRD3TSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP disclosed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO disclosed